Previous studies have suggested that METTL3, a key m6A methyltransferase, inhibits the proliferation and migration of cutaneous T-cell lymphoma (CTCL) cells by regulating the expression of CDKN2A [18]. The gene discussed is CDKN2A; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.